GLP-1 receptor agonists prescribed for diabetes and weight loss have been associated with severe and sometimes permanent gastrointestinal injury — including stomach paralysis (gastroparesis) and intestinal blockage — as well as a serious eye condition (NAION) that can cause sudden vision loss.
Who is affected
- Patients prescribed Ozempic, Wegovy, Rybelsus, or Mounjaro
Conditions and diseases
- Gastroparesis (stomach paralysis)
- Ileus / intestinal obstruction
- Cyclic vomiting syndrome
- NAION (non-arteritic anterior ischemic optic neuropathy)
